Joint PhD project aimed at developing Glycoengineered viral particles as a Platform Technology for Glycoconjugate Vaccines, Immune Modulators and Antivirals

In the framework of an ongoing collaboration between Gaiker and CIC biomaGUNE research centers, it is offered a fully funded 3-year PhD project focused on the development of glycoengineered viral particles and
their validation as conjugate vaccines, immune modulators or antivirals.